Organization: Health Canada
Year: 2020
Month: January
Request Number: A-2019-001180
Request Summary: Information as to whether or not the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review in August 2017 is on “intellectual property hold??? as described in section 6.2 of Health Canada’s Guidance Document on Patented Medicines (Notice of Compliance) Regulations.
Disposition: Disclosed in part
Number of pages: 1